☆ 4.5 Article

Mitochondrial metabolism related markers GDF-15, FGF-21, and HIF-1a are elevated in pediatric migraine attacks

HEADACHE (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Effectiveness and safety of CGRP monoclonal antibodies in migraine related to mitochondrial diseases in patients with NARP and PEO syndromes

Marcello Silvestro et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2023)

Add to Collection

Article Clinical Neurology

FGF-21 and GDF-15 are increased in migraine and associated with the severity of migraine-related disability

Jiahui He et al.

Summary: This study aimed to assess the serum levels of FGF-21 and GDF-15 in migraine patients and their association with migraine-related disability. The study found that levels of FGF-21 and GDF-15 were significantly higher in migraine sufferers compared to healthy controls. Higher levels of FGF-21 were observed in chronic migraine patients compared to episodic migraine patients. Serum levels of FGF-21 and GDF-15 were also associated with the severity of migraine-related disability.

JOURNAL OF HEADACHE AND PAIN (2023)

Add to Collection

Review Clinical Neurology

Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis

Agnese Onofri et al.

Summary: Headache is a common neurological symptom in adults and a major cause of disability worldwide. In children and adolescents, headaches have a significant impact on physical and psychological well-being, but there is limited high-quality evidence available.

JOURNAL OF HEADACHE AND PAIN (2023)

Add to Collection

Review Clinical Neurology

Brain barriers and their potential role in migraine pathophysiology

Astrid Wiggers et al.

Summary: Migraine is a neurological disease involving peptides that can induce vasodilation and affect pain transmission. There is debate whether these peptides act within or outside the central nervous system. Dysfunction of brain barriers during migraine attacks is speculated to facilitate the passage of migraine-inducing peptides into the central nervous system.

JOURNAL OF HEADACHE AND PAIN (2022)

Add to Collection

Review Neurosciences

Current perspectives on mitochondrial dysfunction in migraine

Shraman Kumar Bohra et al.

Summary: This review examines the relationship between mitochondrial dysfunction and migraines, discussing various factors that can affect mitochondrial function and exploring the genetic and epigenetic basis of migraines. Additionally, therapeutic supplements for managing migraines are discussed.

EUROPEAN JOURNAL OF NEUROSCIENCE (2022)

Add to Collection

Article Clinical Neurology

The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system

Arzu Citak et al.

Summary: This study investigated the effects of certain transient receptor potential channels and voltage-gated potassium channels on the release of calcitonin gene-related peptide. The results showed that agonists of these channels induced the release of calcitonin gene-related peptide, which could be blocked or reduced by specific antagonists and retigabine. This suggests that antagonists of these channels or retigabine may be effective in migraine therapy by inhibiting the neurogenic inflammation that requires calcitonin gene-related peptide release.

CEPHALALGIA (2022)

Add to Collection

Article Clinical Neurology

CGRP and PACAP-38 play an important role in diagnosing pediatric migraine

Junhui Liu et al.

Summary: This study investigated the potential diagnostic value of CGRP and PACAP-38 in pediatric migraines. The results showed that CGRP and PACAP-38 levels were elevated in pediatric migraine patients, with higher levels in patients with aura. ROC and logistic regression analyses indicated that CGRP and PACAP-38 are good indicators for diagnosing and differentiating pediatric migraines, with the combination of both showing the highest diagnostic value.

JOURNAL OF HEADACHE AND PAIN (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Mitochondrial Dysfunction and Oxidative Stress in Rheumatoid Arthritis

Maria Jose Lopez-Armada et al.

Summary: Controlling excessive mitochondrial oxidative stress can provide new targets for the treatment of chronic inflammation or diseases such as rheumatoid arthritis (RA). Mitochondrial alterations play a role in autoimmune diseases through the interaction between metabolism and innate immunity. Mitochondrial dysfunction can activate inflammatory pathways and impact cell death and epigenetic regulation. Additionally, there may be a relationship between dietary components and the onset and progression of RA.

ANTIOXIDANTS (2022)

Add to Collection

Article Clinical Neurology

Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods

Fatma Hanci et al.

Summary: The study found that plasma levels of PACAP-38 and vasoactive intestinal peptide were higher in pediatric migraine patients compared to controls, while levels of calcitonin gene-related peptide and substance P remained unchanged. No significant difference in neuropeptide levels was found between attack and attack-free periods.

CEPHALALGIA (2021)

Add to Collection

Article Biochemistry & Molecular Biology

GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH

Kook Hwan Kim et al.

Summary: This review highlights the mechanism of GDF15 expression in response to organelle stress, particularly mitochondrial stress, and its association with pathophysiological conditions or diseases. It emphasizes the dual systemic effects of GDF15 in response to mitochondrial stress, serving as a potential mitokine.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2021)

Add to Collection

Article Multidisciplinary Sciences

Mitochondrial function and oxidative stress markers in higher-frequency episodic migraine

Elena C. Gross et al.

Summary: This study indicates abnormalities in mitochondrial function, oxidative stress, and metabolism in migraine patients, with potential as therapeutic targets. Further research is needed to replicate these results, particularly through comparison with a control group.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Cell Biology

The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine

Philipp Burow et al.

Summary: The study found that serum levels of GDF-15 were higher in migraine patients compared to controls, while FGF-21 levels did not differ. There was no correlation between the biomarkers and headache frequency, but GDF-15 levels were positively associated with age and FGF-21 levels were influenced by BMI. Confounding factors such as age and BMI should be considered in interpreting previous studies on this topic.

CELLS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice

Sara Perez-Pereda et al.

MOLECULAR BIOLOGY REPORTS (2020)

Add to Collection

Article Neurosciences

Effects of estrogen and progesterone on the neurogenic inflammatory neuropeptides: implications for gender differences in migraine

Ayhan Cetinkaya et al.

EXPERIMENTAL BRAIN RESEARCH (2020)

Add to Collection

Article Physiology

The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?

Samuel N. Breit et al.

Annual Review of Physiology (2020)

Add to Collection

Article Clinical Neurology

ROS/TRPA1/CGRP signaling mediates cortical spreading depression

Liwen Jiang et al.

JOURNAL OF HEADACHE AND PAIN (2019)

Add to Collection

Article Pharmacology & Pharmacy

Effect of TRPA1 activator allyl isothiocyanate (AITC) on rat dural and pial arteries

Anna Koldbro Hansted et al.

PHARMACOLOGICAL REPORTS (2019)

Add to Collection

Article Clinical Neurology

Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats

Kirk W. Johnson et al.

CEPHALALGIA (2019)

Add to Collection

Review Clinical Neurology

Gender aspects of CGRP in migraine

Alejandro Labastida-Ramirez et al.

CEPHALALGIA (2019)

Add to Collection

Article Neurosciences

A study of oxidative stress in migraine with special reference to prophylactic therapy

Gyanesh M. Tripathi et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2018)

Add to Collection

Article Clinical Neurology

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

Jes Olesen

CEPHALALGIA (2018)

Add to Collection

Review Clinical Neurology

PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma

James A. Waschek et al.

JOURNAL OF HEADACHE AND PAIN (2018)

Add to Collection

Review Cell Biology

Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases

Ana Luisa Cardoso et al.

AGEING RESEARCH REVIEWS (2018)

Add to Collection

Review Cell Biology

The Role of Mitochondria in Reactive Oxygen Species Generation and Its Implications for Neurodegenerative Diseases

Saima Kausar et al.

CELLS (2018)

Add to Collection

Review Clinical Neurology

Sex differences in the epidemiology, clinical features, and CrossMark pathophysiology of migraine

Kjersti Grotta Vetvik et al.

LANCET NEUROLOGY (2017)

Add to Collection

Review Physiology

PATHOPHYSIOLOGY OF MIGRAINE: A DISORDER OF SENSORY PROCESSING

Peter J. Goadsby et al.

PHYSIOLOGICAL REVIEWS (2017)

Add to Collection

Article Clinical Neurology

Prevalence of migraine in persons with the 3243A>G mutation in mitochondrial DNA

S. Guo et al.

EUROPEAN JOURNAL OF NEUROLOGY (2016)

Add to Collection

Article Pharmacology & Pharmacy

TRPA1 activation leads to neurogenic vasodilatation: involvement of reactive oxygen nitrogen species in addition to CGRP and NO

Aisah A. Aubdool et al.

BRITISH JOURNAL OF PHARMACOLOGY (2016)

Add to Collection

Article Clinical Neurology

Sex hormones in women with and without migraine: Evidence of migraine-specific hormone profiles

Jelena M. Pavlovic et al.

NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases

Ryan L. Davis et al.

NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

Gender influences headache characteristics with increasing age in migraine patients

Hayrunnisa Bolay et al.

CEPHALALGIA (2015)

Add to Collection

Article Clinical Neurology

Decreased antioxidant status in migraine patients with brain white matter hyperintensities

Bilal Aytac et al.

NEUROLOGICAL SCIENCES (2014)

Add to Collection

Review Clinical Neurology

Epidemiology of Migraine and Headache in Children and Adolescents

Cicek Woeber-Bingoel

CURRENT PAIN AND HEADACHE REPORTS (2013)

Add to Collection

Article Clinical Neurology

31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients

Harmen Reyngoudt et al.

CEPHALALGIA (2011)

Add to Collection

Article Clinical Neurology

Oxidative stress is associated with migraine and migraine-related metabolic risk in females

C. Bernecker et al.

EUROPEAN JOURNAL OF NEUROLOGY (2011)

Add to Collection

Review Medicine, General & Internal

Mechanisms of Disease: Hypoxia and Inflammation.

Holger K. Eltzschig et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Add to Collection

Article Biochemistry & Molecular Biology

The fasting polypeptide FGF21 can enter brain from blood

Hung Hsuchou et al.

PEPTIDES (2007)

Add to Collection

Article Chemistry, Multidisciplinary

Characteristics of substance P transport across the blood-brain barrier

Arvind K. Chappa et al.

PHARMACEUTICAL RESEARCH (2006)

Add to Collection

Review Clinical Neurology

Mitochondrial dysfunction and migraine: evidence and hypotheses

M Sparaco et al.

CEPHALALGIA (2006)

Add to Collection

Review Pharmacology & Pharmacy

Passage of VIP/PACAP/secretin family across the blood-brain barrier: Therapeutic effects

D Dogrukol-Ak et al.

CURRENT PHARMACEUTICAL DESIGN (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.